Mico 12 Injection: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
GLOW Blend is a wellness-focused peptide program that combines BPC-157, TB-500, and GHK-Cu for recovery support, mobility support, skin health, collagen support, and regenerative wellness goals
Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
